Corona, Laura L. http://orcid.org/0000-0001-8166-253X
Wagner, Liliana
Wade, Joshua
Weitlauf, Amy S.
Hine, Jeffrey
Nicholson, Amy
Stone, Caitlin
Vehorn, Alison
Warren, Zachary
Funding for this research was provided by:
NIH/NIMH (R21MH118539)
National Institutes of Health (R43MH115528, R44MH115528)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54 HD08321)
Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston (5UL1TR002243-03)
Article History
Accepted: 19 December 2020
First Online: 8 January 2021
Compliance with Ethical Standards
:
: Joshua Wade is the CEO and Co-founder of Adaptive Technology Consulting. Dr. Warren has served as a Consultant for Adaptive Technology Consulting and Roche. Dr. Weitlauf has served as a Consultant for Adaptive Technology Consulting.
: All procedures performed in this study were in accordance with the Ethical Standards of the Institutional Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Analysis of existing clinical data was approved by the Institutional Review Board at Vanderbilt University Medical Center.
Free to read: This content has been made available to all.